Description
Erlotinib – Targeted Therapy for Lung and Pancreatic Cancer
Erlotinib is a prescription tyrosine kinase inhibitor (TKI) used as a targeted therapy for certain types of cancers. It is primarily prescribed for non-small cell lung cancer (NSCLC) with EGFR (epidermal growth factor receptor) mutations and for advanced pancreatic cancer in combination with gemcitabine. Erlotinib works by blocking the activity of the EGFR protein, which is responsible for cancer cell growth and division, thereby slowing disease progression and improving survival outcomes.
At Oncomed Pharmacy, we provide genuine Erlotinib tablets from trusted manufacturers, ensuring patients have access to safe, effective, and high-quality targeted cancer therapies.
Key Features of Erlotinib
- Indications:
o Non-small cell lung cancer (NSCLC) with EGFR mutations
o Advanced pancreatic cancer (in combination with gemcitabine)
- Formulation: Oral tablets, available in multiple strengths.
- Mechanism of Action: Tyrosine kinase inhibitor that blocks EGFR signaling, preventing tumor cell proliferation.
- Patient Benefit: Offers targeted cancer therapy with fewer side effects compared to traditional chemotherapy.
Why Buy Erlotinib from Oncomed Pharmacy?
- 100% authentic and quality-assured oncology medicines.
- Competitive pricing with countrywide delivery.
- Available in different dosage strengths for personalized treatment.
- Trusted global supplier specializing in targeted therapies and cancer medicines.
Uses of Erlotinib
- First-line treatment for EGFR-positive non-small cell lung cancer (NSCLC).
- Combination therapy for advanced pancreatic cancer with gemcitabine.
- Maintenance therapy in NSCLC after initial chemotherapy.
Reviews
There are no reviews yet.